tldrdaily.news logo

Eli Lilly's Obesity Pill Shows Mixed Results in Recent Trials

1 min read
Source: WIRED
Eli Lilly's Obesity Pill Shows Mixed Results in Recent Trials
Photo: WIRED
TL;DR Summary

Eli Lilly's experimental GLP-1 pill, forforglipron, showed promising results in an 18-month trial, with about 60% of participants losing at least 10% of their body weight and an average loss of over 12%, offering a potential alternative to existing obesity treatments.

Topics:business#clinical-trial#eli-lilly#glp-1-pill#health#obesity#weight-loss
Share this article
  1. Eli Lilly’s Obesity Pill Shows Promising Weight Loss in New Results  WIRED
  2. We're downgrading Lilly and asking ourselves tough questions after its obesity pill letdown  CNBC
  3. Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity | Eli Lilly and Company  Eli Lilly and Company
  4. Danish drugmakers jump as Eli Lilly's weight-loss pill data disappoints  Reuters
  5. Lilly Obesity Pill Cut Weight by Just 11% in Study; Shares Drop  Bloomberg.com

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

1 min

vs 1 min read

Condensed

79%

193 → 41 words

Want the full story? Read the original article

Read on WIRED